The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Pharmacology Research & Perspectives
(Aug 2024)
FDA regulatory considerations for oncology drug development
Hanlim Moon,
Dae Young Zang,
Min‐Hee Ryu,
YeonSook Seo,
Bitna Oh,
Sunjin Hwang,
Lee Farrand
Affiliations
Hanlim Moon
MediRama, Inc. Seoul South Korea
Dae Young Zang
Department of Internal Medicine, College of Medicine, Hallym University Hallym University Sacred Heart Hospital Anyang‐si South Korea
Min‐Hee Ryu
Department of Oncology University of Ulsan College of Medicine, Asan Medical Center Seoul South Korea
YeonSook Seo
MediRama, Inc. Seoul South Korea
Bitna Oh
MediRama, Inc. Seoul South Korea
Sunjin Hwang
MediRama, Inc. Seoul South Korea
Lee Farrand
MediRama, Inc. Seoul South Korea
DOI
https://doi.org/10.1002/prp2.1254
Journal volume & issue
Vol. 12, no. 4
pp. n/a – n/a
Abstract
Read online
No abstracts available.
WeChat QR code
Close